Efficacy News and Research

RSS
FDA grants Orphan Drug Designation for Accentia's Revimmune to prevent GVHD

FDA grants Orphan Drug Designation for Accentia's Revimmune to prevent GVHD

Positive data from Aeterna Zentaris' AEZS-108 Phase 2 study on advanced endometrial cancer

Positive data from Aeterna Zentaris' AEZS-108 Phase 2 study on advanced endometrial cancer

New data from Pfizer's investigational oncology compounds to be presented at EMCC 2011

New data from Pfizer's investigational oncology compounds to be presented at EMCC 2011

Merck issues statement on GARDASIL human papillomavirus vaccine

Merck issues statement on GARDASIL human papillomavirus vaccine

Nanobiotix starts clinical trial of new cancer treatment for soft tissue sarcoma

Nanobiotix starts clinical trial of new cancer treatment for soft tissue sarcoma

VIVUS presents positive results from avanafil phase 3 study in diabetics at 47th EASD meeting

VIVUS presents positive results from avanafil phase 3 study in diabetics at 47th EASD meeting

AM-Pharma announces €29.2m series D round of financing

AM-Pharma announces €29.2m series D round of financing

Delcath announces updated Phase 2 trial results from metastatic neuroendocrine tumor cohort

Delcath announces updated Phase 2 trial results from metastatic neuroendocrine tumor cohort

ADI releases World Alzheimer Report 2011

ADI releases World Alzheimer Report 2011

Researchers use MRI and PET/CT to assess safety, efficacy of heart drug dalcetrapib

Researchers use MRI and PET/CT to assess safety, efficacy of heart drug dalcetrapib

Positive data from NovaDigm's NDV-3 vaccine program to be presented at ICAAC conference

Positive data from NovaDigm's NDV-3 vaccine program to be presented at ICAAC conference

ImmunoCellular announces updated long-term data from ICT-107 Phase I trial on GBM

ImmunoCellular announces updated long-term data from ICT-107 Phase I trial on GBM

Clinical trial planned in Australia and the USA to help patients with ‘orphan’ disease

Clinical trial planned in Australia and the USA to help patients with ‘orphan’ disease

Sanofi's Lyxumia achieves primary efficacy endpoint in study of patients uncontrolled on metformin

Sanofi's Lyxumia achieves primary efficacy endpoint in study of patients uncontrolled on metformin

BioSante reports top-line results from LibiGel PK study for HSDD in postmenopausal women

BioSante reports top-line results from LibiGel PK study for HSDD in postmenopausal women

IsoRay receives FDA clearance for GliaSite radiation therapy system to treat brain cancer

IsoRay receives FDA clearance for GliaSite radiation therapy system to treat brain cancer

Spinifex announces new data from EMA401 pre-clinical study on diabetic neuropathy

Spinifex announces new data from EMA401 pre-clinical study on diabetic neuropathy

Diamyd receives NIH grant to develop NTDDS for Chemotherapy Induced Peripheral Neuropathy

Diamyd receives NIH grant to develop NTDDS for Chemotherapy Induced Peripheral Neuropathy

InteRNA, Silence partner to develop novel microRNA therapeutics for cancer

InteRNA, Silence partner to develop novel microRNA therapeutics for cancer

HPV vaccination updates

HPV vaccination updates

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.